David Dean Halbert

David Dean Halbert

David Dean Halbert (#2139)

Global Rank #2139
Country Rank #703
Country United States

I fundamentally believed that if there was something wrong with the human body, there was something misfiring at the molecular level and technology advances could find that and diagnose it and possibly treat it.

  • $ 2 B
  • Biotech
  • United States
  • M
  • 70 Years

Snapshot

Quick Facts

Global Rank #2,139
Country Rank #703
Net Worth $2.0B
Previous Worth $2.0B
Worth Change +$0.0B
Country United States
Industry Biotech
Age 70 Years
Gender M
Worth As Of May 4, 2026
Residence Colleyville, Texas
Citizenship United States

Profile Data

Personal Stats

Age 70
Source Of Wealth Biotech, Self Made
Self Made Score 7
Philanthropy Score 2
Residence Colleyville, Texas
Citizenship United States
Marital Status Married
Children 3
Education Bachelor of Business Administration, Abilene Christian University
Net Worth Change +$0.0B +0.0% from previous worth
Previous Net Worth $2.0B
Current Net Worth $2.0B

Worth as of May 4, 2026

About Me

David Dean Halbert became a billionaire in June 2025 when the diagnostics firm he built up, Caris Life Sciences, went public on the Nasdaq. In 2008 Halbert acquired a small biotech firm called Molecular Profiling Institute, then greatly expanded it and renamed it Caris Life Sciences; he owns a 44% stake. Caris Life Sciences uses gene sequencing, AI and machine learning for early disease detection; revenue at the unprofitable company grew to $412 million in 2024. Halbert previously founded pharmacy benefit manager AdvancePCS in 1987. He took it public and later sold it to Caremark for $7.5 billion in 2004 He has been an active buyer and seller of healthcare businesses through his Caris Capital.

Achievements

Forbes List Highlights

A snapshot of the list placements and rankings connected to David Dean Halbert.

#1611
Billionaires (2026)
#308
Forbes 400 (2025)

Wealth Growth

Net Worth Growth Over Time

Tracking David Dean Halbert's net worth journey over the years, highlighting key growth phases and financial milestones.